Skip to main content
Erschienen in: Breast Cancer Research and Treatment 2/2013

01.06.2013 | Epidemiology

Patient–physician interaction and quality of life in recently diagnosed breast cancer patients

verfasst von: Marilyn L. Kwan, Emily K. Tam, Isaac J. Ergas, David H. Rehkopf, Janise M. Roh, Marion M. Lee, Carol P. Somkin, Anita L. Stewart, Lawrence H. Kushi

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Few studies have explored how patient–physician interactions influence patients’ quality of life (QOL). In a prospective cohort study of 1,855 women diagnosed with invasive breast cancer in the Kaiser Permanente Northern California Medical Care Program from 2006 to 2011, we examined associations between patient–physician interactions during cancer treatment and QOL, overall and by racial/ethnic group. Participants completed the interpersonal processes of care (IPC) survey at approximately 8 months post-diagnosis to assess specific domains of the patient–physician interaction during the months after cancer diagnosis. Domains included: compassion, elicited concerns, explained results, decided together, lack of clarity, discrimination due to race/ethnicity, and disrespectful office staff. The functional assessment of cancer therapy-breast cancer was completed concurrently to measure QOL. Linear regression models examined the association of IPC with QOL, first adjusting for patient covariates including age, race, clinical factors, and psychosocial measures and then for physician characteristics such as age, sex, race/ethnicity, and specialty. For all participants (n = 1,855), IPC scores suggesting greater lack of clarity, discrimination due to race/ethnicity, and disrespectful office staff in patient–physician interactions were associated with lower QOL (P< 0.01). IPC scores suggesting physicians demonstrating compassion, eliciting concerns, or explaining results were associated with higher QOL (P< 0.01). Among Whites (n = 1,306), only the associations with higher QOL remained. African Americans (n = 110) who reported higher scores on physician compassion and elicited concerns had higher QOL, whereas higher scores for disrespectful office staff had lower QOL. No associations were observed among Asians (n = 201) and Hispanics (n = 186). After further adjustment for physician factors, the associations among Whites remained, whereas those among African Americans disappeared. In the breast cancer treatment setting, characteristics of the patient–physician interaction as perceived by the patient are associated with QOL, yet were not specific to patient race/ethnicity.
Literatur
1.
Zurück zum Zitat Future, I.f.t. (2000) Health and health care 2010. Robert Wood Johnson Foundation, Princeton Future, I.f.t. (2000) Health and health care 2010. Robert Wood Johnson Foundation, Princeton
2.
Zurück zum Zitat American Cancer Society (2009) Breast cancer facts and figures. 2009–2010. American Cancer Society, Inc, Atlanta American Cancer Society (2009) Breast cancer facts and figures. 2009–2010. American Cancer Society, Inc, Atlanta
3.
Zurück zum Zitat Li CI, Malone KE, Daling JR (2003) Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 163(1):49–56PubMedCrossRef Li CI, Malone KE, Daling JR (2003) Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 163(1):49–56PubMedCrossRef
4.
Zurück zum Zitat Ooi SL, Martinez ME, Li CI (2011) Disparities in breast cancer characteristics and outcomes by race/ethnicity. Breast Cancer Res Treat 127(3):729–738PubMedCrossRef Ooi SL, Martinez ME, Li CI (2011) Disparities in breast cancer characteristics and outcomes by race/ethnicity. Breast Cancer Res Treat 127(3):729–738PubMedCrossRef
5.
Zurück zum Zitat American Cancer Society (2011) Breast Cancer Facts & Figures 2011–2012. American Cancer Society Inc, Atlanta American Cancer Society (2011) Breast Cancer Facts & Figures 2011–2012. American Cancer Society Inc, Atlanta
6.
Zurück zum Zitat Ayanian JZ, Zaslavsky AM, Arora NK, Kahn KL, Malin JL, Ganz PA, van Ryn M, Hornbrook MC, Kiefe CI, He Y, Urmie JM, Weeks JC, Harrington DP (2010) Patients’ experiences with care for lung cancer and colorectal cancer: findings from the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol 28(27):4154–4161PubMedCrossRef Ayanian JZ, Zaslavsky AM, Arora NK, Kahn KL, Malin JL, Ganz PA, van Ryn M, Hornbrook MC, Kiefe CI, He Y, Urmie JM, Weeks JC, Harrington DP (2010) Patients’ experiences with care for lung cancer and colorectal cancer: findings from the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol 28(27):4154–4161PubMedCrossRef
7.
Zurück zum Zitat Ayanian JZ, Zaslavsky AM, Guadagnoli E, Fuchs CS, Yost KJ, Creech CM, Cress RD, O’Connor LC, West DW, Wright WE (2005) Patients’ perceptions of quality of care for colorectal cancer by race, ethnicity, and language. J Clin Oncol 23(27):6576–6586PubMedCrossRef Ayanian JZ, Zaslavsky AM, Guadagnoli E, Fuchs CS, Yost KJ, Creech CM, Cress RD, O’Connor LC, West DW, Wright WE (2005) Patients’ perceptions of quality of care for colorectal cancer by race, ethnicity, and language. J Clin Oncol 23(27):6576–6586PubMedCrossRef
8.
Zurück zum Zitat Sherlaw-Johnson C, Datta P, McCarthy M (2008) Hospital differences in patient satisfaction with care for breast, colorectal, lung and prostate cancers. Eur J Cancer 44(11):1559–1565PubMedCrossRef Sherlaw-Johnson C, Datta P, McCarthy M (2008) Hospital differences in patient satisfaction with care for breast, colorectal, lung and prostate cancers. Eur J Cancer 44(11):1559–1565PubMedCrossRef
9.
Zurück zum Zitat Wong ST, Korenbrot CC, Stewart AL (2004) Consumer assessment of the quality of interpersonal processes of prenatal care among ethnically diverse low-income women: development of a new measure. Womens Health Issues 14(4):118–129PubMedCrossRef Wong ST, Korenbrot CC, Stewart AL (2004) Consumer assessment of the quality of interpersonal processes of prenatal care among ethnically diverse low-income women: development of a new measure. Womens Health Issues 14(4):118–129PubMedCrossRef
10.
Zurück zum Zitat Waters EA, Arora NK, Klein WM, Han PK (2010) Perceived risk, trust and health-related quality of life among cancer survivors. Ann Behav Med 39(1):91–97PubMedCrossRef Waters EA, Arora NK, Klein WM, Han PK (2010) Perceived risk, trust and health-related quality of life among cancer survivors. Ann Behav Med 39(1):91–97PubMedCrossRef
11.
Zurück zum Zitat Leak A, Hu J, King CR (2008) Symptom distress, spirituality, and quality of life in African American breast cancer survivors. Cancer Nurs 31(1):E15–E21PubMedCrossRef Leak A, Hu J, King CR (2008) Symptom distress, spirituality, and quality of life in African American breast cancer survivors. Cancer Nurs 31(1):E15–E21PubMedCrossRef
12.
Zurück zum Zitat Powe BD, Hamilton J, Hancock N, Johnson N, Finnie R, Ko J, Brooks P, Boggan M Jr (2007) Quality of life of African American cancer survivors. A review of the literature. Cancer 109(2 Suppl):435–445PubMedCrossRef Powe BD, Hamilton J, Hancock N, Johnson N, Finnie R, Ko J, Brooks P, Boggan M Jr (2007) Quality of life of African American cancer survivors. A review of the literature. Cancer 109(2 Suppl):435–445PubMedCrossRef
13.
Zurück zum Zitat Yi JK, Swartz MD, Reyes-Gibby CC (2011) English proficiency, symptoms, and quality of life in Vietnamese- and Chinese-American breast cancer survivors. J Pain Symptom Manag 42(1):83–92CrossRef Yi JK, Swartz MD, Reyes-Gibby CC (2011) English proficiency, symptoms, and quality of life in Vietnamese- and Chinese-American breast cancer survivors. J Pain Symptom Manag 42(1):83–92CrossRef
14.
Zurück zum Zitat Kwan ML, Ambrosone CB, Lee MM, Barlow J, Krathwohl SE, Ergas IJ, Ashley CH, Bittner JR, Darbinian J, Stronach K, Caan BJ, Davis W, Kutner SE, Quesenberry CP, Somkin CP, Sternfeld B, Wiencke JK, Zheng S, Kushi LH (2008) The pathways study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California. Cancer Causes Control 19(10):1065–1076PubMedCrossRef Kwan ML, Ambrosone CB, Lee MM, Barlow J, Krathwohl SE, Ergas IJ, Ashley CH, Bittner JR, Darbinian J, Stronach K, Caan BJ, Davis W, Kutner SE, Quesenberry CP, Somkin CP, Sternfeld B, Wiencke JK, Zheng S, Kushi LH (2008) The pathways study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California. Cancer Causes Control 19(10):1065–1076PubMedCrossRef
15.
Zurück zum Zitat Stewart AL, Napoles-Springer AM, Gregorich SE, Santoyo-Olsson J (2007) Interpersonal processes of care survey: patient-reported measures for diverse groups. Health Serv Res 42(3 Pt 1):1235–1256PubMedCrossRef Stewart AL, Napoles-Springer AM, Gregorich SE, Santoyo-Olsson J (2007) Interpersonal processes of care survey: patient-reported measures for diverse groups. Health Serv Res 42(3 Pt 1):1235–1256PubMedCrossRef
16.
Zurück zum Zitat Napoles AM, Gregorich SE, Santoyo-Olsson J, O’Brien H, Stewart AL (2009) Interpersonal processes of care and patient satisfaction: do associations differ by race, ethnicity, and language? Health Serv Res 44(4):1326–1344PubMedCrossRef Napoles AM, Gregorich SE, Santoyo-Olsson J, O’Brien H, Stewart AL (2009) Interpersonal processes of care and patient satisfaction: do associations differ by race, ethnicity, and language? Health Serv Res 44(4):1326–1344PubMedCrossRef
17.
Zurück zum Zitat Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J et al (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570–579PubMed Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J et al (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570–579PubMed
18.
Zurück zum Zitat Oehrli MD, Quesenberry CP, Leyden WA, 2011 Annual Report on Trends, Incidence, and Outcomes. Kaiser Permanente, Northern California Cancer Registry, 2011 Oehrli MD, Quesenberry CP, Leyden WA, 2011 Annual Report on Trends, Incidence, and Outcomes. Kaiser Permanente, Northern California Cancer Registry, 2011
19.
Zurück zum Zitat Scheier MF, Carver CS, Bridges MW (1994) Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the Life Orientation Test. J Pers Soc Psychol 67(6):1063–1078PubMedCrossRef Scheier MF, Carver CS, Bridges MW (1994) Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the Life Orientation Test. J Pers Soc Psychol 67(6):1063–1078PubMedCrossRef
20.
21.
Zurück zum Zitat Stevens GD, Shi L, Cooper LA (2003) Patient-provider racial and ethnic concordance and parent reports of the primary care experiences of children. Ann Fam Med 1(2):105–112PubMedCrossRef Stevens GD, Shi L, Cooper LA (2003) Patient-provider racial and ethnic concordance and parent reports of the primary care experiences of children. Ann Fam Med 1(2):105–112PubMedCrossRef
22.
Zurück zum Zitat Jerant A, Bertakis KD, Fenton JJ, Tancredi DJ, Franks P (2011) Patient-provider sex and race/ethnicity concordance: a national study of healthcare and outcomes. Med Care 49(11):1012–1020PubMedCrossRef Jerant A, Bertakis KD, Fenton JJ, Tancredi DJ, Franks P (2011) Patient-provider sex and race/ethnicity concordance: a national study of healthcare and outcomes. Med Care 49(11):1012–1020PubMedCrossRef
23.
Zurück zum Zitat Blanchard J, Nayar S, Lurie N (2007) Patient-provider and patient-staff racial concordance and perceptions of mistreatment in the health care setting. J Gen Intern Med 22(8):1184–1189PubMedCrossRef Blanchard J, Nayar S, Lurie N (2007) Patient-provider and patient-staff racial concordance and perceptions of mistreatment in the health care setting. J Gen Intern Med 22(8):1184–1189PubMedCrossRef
24.
Zurück zum Zitat Cooper LA, Powe NR (2004) Disparities in patient experiences, health care processes, and outcomes: the role of patient-provider racial, ethnic, and language concordance. The Commonwealth Fund, New York Cooper LA, Powe NR (2004) Disparities in patient experiences, health care processes, and outcomes: the role of patient-provider racial, ethnic, and language concordance. The Commonwealth Fund, New York
25.
Zurück zum Zitat Street RL Jr, O’Malley KJ, Cooper LA, Haidet P (2008) Understanding concordance in patient-physician relationships: personal and ethnic dimensions of shared identity. Ann Fam Med 6(3):198–205PubMedCrossRef Street RL Jr, O’Malley KJ, Cooper LA, Haidet P (2008) Understanding concordance in patient-physician relationships: personal and ethnic dimensions of shared identity. Ann Fam Med 6(3):198–205PubMedCrossRef
26.
Zurück zum Zitat Schmittdiel J, Grumbach K, Selby JV, Quesenberry CP Jr (2000) Effect of physician and patient gender concordance on patient satisfaction and preventive care practices. J Gen Intern Med 15(11):761–769PubMedCrossRef Schmittdiel J, Grumbach K, Selby JV, Quesenberry CP Jr (2000) Effect of physician and patient gender concordance on patient satisfaction and preventive care practices. J Gen Intern Med 15(11):761–769PubMedCrossRef
27.
Zurück zum Zitat Schenker Y, Karter AJ, Schillinger D, Warton EM, Adler NE, Moffet HH, Ahmed AT, Fernandez A (2010) The impact of limited English proficiency and physician language concordance on reports of clinical interactions among patients with diabetes: the DISTANCE study. Patient Educ Couns 81(2):222–228PubMedCrossRef Schenker Y, Karter AJ, Schillinger D, Warton EM, Adler NE, Moffet HH, Ahmed AT, Fernandez A (2010) The impact of limited English proficiency and physician language concordance on reports of clinical interactions among patients with diabetes: the DISTANCE study. Patient Educ Couns 81(2):222–228PubMedCrossRef
28.
Zurück zum Zitat Alexandraki I, Mooradian AD (2010) Barriers related to mammography use for breast cancer screening among minority women. J Natl Med Assoc 102(3):206–218PubMed Alexandraki I, Mooradian AD (2010) Barriers related to mammography use for breast cancer screening among minority women. J Natl Med Assoc 102(3):206–218PubMed
29.
Zurück zum Zitat Bennett JK, Fuertes JN, Keitel M, Phillips R (2011) The role of patient attachment and working alliance on patient adherence, satisfaction, and health-related quality of life in lupus treatment. Patient Educ Couns 85(1):53–59PubMedCrossRef Bennett JK, Fuertes JN, Keitel M, Phillips R (2011) The role of patient attachment and working alliance on patient adherence, satisfaction, and health-related quality of life in lupus treatment. Patient Educ Couns 85(1):53–59PubMedCrossRef
30.
Zurück zum Zitat Lyles CR, Karter AJ, Young BA, Spigner C, Grembowski D, Schillinger D, Adler N (2011) Provider factors and patient-reported healthcare discrimination in the Diabetes Study of California (DISTANCE). Patient Educ Couns 85(3):e216–e224PubMedCrossRef Lyles CR, Karter AJ, Young BA, Spigner C, Grembowski D, Schillinger D, Adler N (2011) Provider factors and patient-reported healthcare discrimination in the Diabetes Study of California (DISTANCE). Patient Educ Couns 85(3):e216–e224PubMedCrossRef
Metadaten
Titel
Patient–physician interaction and quality of life in recently diagnosed breast cancer patients
verfasst von
Marilyn L. Kwan
Emily K. Tam
Isaac J. Ergas
David H. Rehkopf
Janise M. Roh
Marion M. Lee
Carol P. Somkin
Anita L. Stewart
Lawrence H. Kushi
Publikationsdatum
01.06.2013
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 2/2013
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-013-2569-z

Weitere Artikel der Ausgabe 2/2013

Breast Cancer Research and Treatment 2/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.